Stegostoma fasciatum isolate 6-17 chromosome 22, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039248.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
solute carrier family 6 member 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 6 member 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent neutral amino acid transporter SLC6A17 isoform X1
sodium-dependent neutral amino acid transporter SLC6A17 isoform X2
potassium voltage-gated channel subfamily C member 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 1-like
solute carrier family 16 member 4, transcript variant X2
solute carrier family 16 member 4, transcript variant X3
solute carrier family 16 member 4, transcript variant X4
solute carrier family 16 member 4, transcript variant X1
monocarboxylate transporter 5 isoform X2
monocarboxylate transporter 5 isoform X3
monocarboxylate transporter 5 isoform X1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
MyoD family inhibitor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MyoD family inhibitor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor EB-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor EB-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor EB-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription factor EB-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
family with sequence similarity 72 member A
SLIT-ROBO Rho GTPase activating protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
SLIT-ROBO Rho GTPase-activating protein 2
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase TBK1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ataxin-7-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
probable transmembrane reductase CYB561D1, transcript variant X1
probable transmembrane reductase CYB561D1 isoform X1
probable transmembrane reductase CYB561D1, transcript variant X2
probable transmembrane reductase CYB561D1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein phosphatase non-receptor type 22-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein PHTF1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein PHTF1-like, transcript variant X1
protein PHTF1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X6
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X8
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X4
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X5
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X3
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X6
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X8
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X5
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X1
membrane associated guanylate kinase, WW and PDZ domain containing 3a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3a isoform X7
leucine-rich repeats and immunoglobulin-like domains 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
leucine-rich repeats and immunoglobulin-like domains 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
leucine-rich repeats and immunoglobulin-like domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X2
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X3
leucine-rich repeats and immunoglobulin-like domains protein 2 isoform X1
monocarboxylate transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
monocarboxylate transporter 1-like, transcript variant X5
monocarboxylate transporter 1-like, transcript variant X6
monocarboxylate transporter 1-like, transcript variant X1
monocarboxylate transporter 1-like, transcript variant X2
monocarboxylate transporter 1-like, transcript variant X4
TAFA chemokine like family member 3b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TAFA chemokine like family member 3b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TAFA chemokine like family member 3b, transcript variant X2
chemokine-like protein TAFA-2 isoform X1
chemokine-like protein TAFA-2 isoform X2
protein phosphatase 1H-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein phosphatase 1H-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
putative helicase MOV-10, transcript variant X2
putative helicase MOV-10, transcript variant X1
capping actin protein of muscle Z-line subunit alpha 1b
F-actin-capping protein subunit alpha-1b
suppressor of tumorigenicity 7 protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein homolog, transcript variant X4
suppressor of tumorigenicity 7 protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein homolog isoform X1
suppressor of tumorigenicity 7 protein-like isoform X4
suppressor of tumorigenicity 7 protein homolog isoform X5
suppressor of tumorigenicity 7 protein homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein homolog isoform X2
suppressor of tumorigenicity 7 protein homolog isoform X3
suppressor of tumorigenicity 7 protein homolog isoform X6
wingless-type MMTV integration site family, member 2Bb
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 104 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAP1A, member of RAS oncogene family a, transcript variant X1
RAP1A, member of RAS oncogene family a, transcript variant X3
RAP1A, member of RAS oncogene family a, transcript variant X2
inka box actin regulator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inka box actin regulator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20
probable ATP-dependent RNA helicase DDX20
potassium voltage-gated channel, Shal-related subfamily, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium voltage-gated channel, Shal-related subfamily, member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel, Shal-related subfamily, member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium voltage-gated channel subfamily D member 3 isoform X2
potassium voltage-gated channel subfamily D member 3 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC125462649
CTTNBP2 N-terminal like b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CTTNBP2 N-terminal like b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ETS domain-containing protein Elk-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
major facilitator superfamily domain-containing protein 4A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclin-dependent kinase 18-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin-dependent kinase 18-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclin-dependent kinase 18-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin-dependent kinase 18-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclin-dependent kinase 18-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclin-dependent kinase 18-like, transcript variant X2
cyclin-dependent kinase 18-like, transcript variant X6
cyclin-dependent kinase 18-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cyclin-dependent kinase 18-like isoform X3
cyclin-dependent kinase 18-like isoform X1
cyclin-dependent kinase 18-like isoform X2
cyclin-dependent kinase 18-like isoform X4
lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma-like, transcript variant X3
lamina-associated polypeptide 2, isoforms beta/gamma-like isoform X3
lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma-like, transcript variant X1
lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma-like, transcript variant X2
lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma-like isoform X1
lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma-like isoform X2
lamina-associated polypeptide 2, isoforms beta/gamma-like isoform X4
kelch domain containing 8A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch domain containing 8A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch domain-containing protein 8A isoform X4
kelch domain-containing protein 8A isoform X1
kelch domain-containing protein 8A isoform X3
kelch domain-containing protein 8A isoform X2
kelch domain-containing protein 8A isoform X5
NUAK family, SNF1-like kinase, 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NUAK family, SNF1-like kinase, 2, transcript variant X4
NUAK family, SNF1-like kinase, 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NUAK family, SNF1-like kinase, 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NUAK family SNF1-like kinase 2 isoform X1
NUAK family SNF1-like kinase 2 isoform X2
NUAK family SNF1-like kinase 1 isoform X3
transmembrane and coiled-coil domain family 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transmembrane and coiled-coil domains protein 2 isoform X4
transmembrane and coiled-coil domain family 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane and coiled-coil domain family 2, transcript variant X1
transmembrane and coiled-coil domain family 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane and coiled-coil domain family 2, transcript variant X6
transmembrane and coiled-coil domains protein 2 isoform X1
transmembrane and coiled-coil domains protein 2 isoform X2
transmembrane and coiled-coil domains protein 2 isoform X5
transmembrane and coiled-coil domains protein 2 isoform X6
transmembrane and coiled-coil domain family 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane and coiled-coil domains protein 2 isoform X3
dual serine/threonine and tyrosine protein kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase, transcript variant X2
dual serine/threonine and tyrosine protein kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual serine/threonine and tyrosine protein kinase isoform X1
dual serine/threonine and tyrosine protein kinase isoform X2
dual serine/threonine and tyrosine protein kinase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
neurofascin homolog (chicken) a, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X3
neurofascin homolog (chicken) a, transcript variant X9
neurofascin homolog (chicken) a, transcript variant X14
neurofascin homolog (chicken) a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurofascin homolog (chicken) a, transcript variant X2
neurofascin homolog (chicken) a isoform X12
neurofascin homolog (chicken) a isoform X7
neurofascin homolog (chicken) a isoform X6
neurofascin homolog (chicken) a isoform X11
neurofascin homolog (chicken) a isoform X2
neurofascin homolog (chicken) a isoform X8
neurofascin homolog (chicken) a isoform X13
neurofascin homolog (chicken) a isoform X5
neurofascin homolog (chicken) a isoform X4
neurofascin homolog (chicken) a isoform X10
neurofascin homolog (chicken) a isoform X9
neurofascin homolog (chicken) a isoform X3
neurofascin homolog (chicken) a isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
leucine-rich repeat neuronal protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich repeat neuronal protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat neuronal protein 2-like
uncharacterized LOC125462727, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125462727, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha-like, transcript variant X1
nuclear transcription factor Y subunit alpha-like, transcript variant X4
nuclear transcription factor Y subunit alpha-like, transcript variant X5
nuclear transcription factor Y subunit alpha-like, transcript variant X6
nuclear transcription factor Y subunit alpha-like, transcript variant X3
nuclear transcription factor Y subunit alpha-like, transcript variant X2
nuclear transcription factor Y subunit alpha-like isoform X1
nuclear transcription factor Y subunit alpha-like isoform X2
nuclear transcription factor Y subunit alpha-like isoform X4
nuclear transcription factor Y subunit alpha-like isoform X3
epidermal growth factor receptor kinase substrate 8-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
epidermal growth factor receptor kinase substrate 8-like protein 3, transcript variant X2
epidermal growth factor receptor kinase substrate 8-like protein 3
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta, transcript variant X2
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta, transcript variant X1
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta, transcript variant X4
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta, transcript variant X3
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X1
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X2
protein phosphatase 1 regulatory subunit 15B-like
pleckstrin homology domain containing, family A member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain containing, family A member 6, transcript variant X4
pleckstrin homology domain containing, family A member 6, transcript variant X2
pleckstrin homology domain containing, family A member 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain containing, family A member 6, transcript variant X3
pleckstrin homology domain containing, family A member 6, transcript variant X8
pleckstrin homology domain containing, family A member 6, transcript variant X9
pleckstrin homology domain containing, family A member 6, transcript variant X5
pleckstrin homology domain-containing family A member 6 isoform X4
pleckstrin homology domain-containing family A member 6 isoform X1
pleckstrin homology domain-containing family A member 6 isoform X2
pleckstrin homology domain-containing family A member 6 isoform X9
pleckstrin homology domain-containing family A member 6 isoform X7
pleckstrin homology domain-containing family A member 6 isoform X3
pleckstrin homology domain-containing family A member 6 isoform X8
pleckstrin homology domain-containing family A member 6 isoform X5
pleckstrin homology domain containing, family A member 6, transcript variant X13
pleckstrin homology domain containing, family A member 6, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology domain containing, family A member 6, transcript variant X12
pleckstrin homology domain containing, family A member 6, transcript variant X10
pleckstrin homology domain containing, family A member 6, transcript variant X14
pleckstrin homology domain containing, family A member 6, transcript variant X6
pleckstrin homology domain-containing family A member 6 isoform X6
pleckstrin homology domain-containing family A member 6 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ethanolamine kinase 2, transcript variant X1
ethanolamine kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transcription factor SOX-13-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcription factor SOX-13-like, transcript variant X6
transcription factor SOX-13-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor SOX-13-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor SOX-13-like, transcript variant X3
transcription factor SOX-13-like, transcript variant X1
transcription factor SOX-13-like isoform X2
transcription factor SOX-13-like isoform X3
transcription factor SOX-13-like isoform X1
transcription factor SOX-13-like isoform X4
small nuclear ribonucleoprotein polypeptide E
zinc finger CCCH-type containing 11A, transcript variant X7
zinc finger CCCH-type containing 11A, transcript variant X4
zinc finger CCCH-type containing 11A, transcript variant X2
zinc finger CCCH-type containing 11A, transcript variant X5
zinc finger CCCH-type containing 11A, transcript variant X9
zinc finger CCCH-type containing 11A, transcript variant X10
zinc finger CCCH-type containing 11A, transcript variant X6
zinc finger CCCH-type containing 11A, transcript variant X3
zinc finger CCCH-type containing 11A, transcript variant X8
zinc finger CCCH-type containing 11A, transcript variant X1
zinc finger CCCH domain-containing protein 11A isoform X2
zinc finger CCCH domain-containing protein 11A isoform X3
zinc finger CCCH domain-containing protein 11A isoform X1
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125462861, transcript variant X4
uncharacterized LOC125462861, transcript variant X2
uncharacterized LOC125462861, transcript variant X5
uncharacterized LOC125462861, transcript variant X3
uncharacterized LOC125462861, transcript variant X6
uncharacterized LOC125462861, transcript variant X1
uncharacterized protein LOC125462861 isoform X2
uncharacterized protein LOC125462861 isoform X1
uncharacterized protein LOC125462861 isoform X4
uncharacterized protein LOC125462861 isoform X3
EF-hand and coiled-coil domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
guanine nucleotide-binding protein G(t) subunit alpha-2
guanine nucleotide-binding protein G(i) subunit alpha-3, transcript variant X1
guanine nucleotide-binding protein G(i) subunit alpha-3, transcript variant X2
guanine nucleotide-binding protein G(i) subunit alpha-3 isoform X1
guanine nucleotide-binding protein G(i) subunit alpha-3 isoform X2
uncharacterized LOC125463024, transcript variant X1
uncharacterized LOC125463024, transcript variant X2
uncharacterized LOC125463024, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC125463024 isoform X2
uncharacterized protein LOC125463024 isoform X1
uncharacterized protein LOC125463024 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
S-adenosylhomocysteine hydrolase-like protein 1
AMP deaminase 2-like, transcript variant X3
AMP deaminase 2-like, transcript variant X2
AMP deaminase 2-like, transcript variant X4
AMP deaminase 2-like, transcript variant X1
AMP deaminase 2-like, transcript variant X6
AMP deaminase 2-like, transcript variant X7
AMP deaminase 2-like, transcript variant X5
Krueppel-like factor 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Krueppel-like factor 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 45 member 3, transcript variant X2
solute carrier family 45 member 3, transcript variant X1
solute carrier family 45 member 3, transcript variant X4
solute carrier family 45 member 3, transcript variant X3
solute carrier family 45 member 3, transcript variant X5
nuclear casein kinase and cyclin-dependent kinase substrate 1a, transcript variant X2
nuclear casein kinase and cyclin-dependent kinase substrate 1a, transcript variant X1
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1a isoform X2
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1a isoform X1
solute carrier family 41 member 1-like, transcript variant X3
solute carrier family 41 member 1-like, transcript variant X4
solute carrier family 41 member 1-like, transcript variant X2
solute carrier family 41 member 1-like, transcript variant X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras-related protein Rab-7b-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ras-related protein Rab-7b-like, transcript variant X1
ras-related protein Rab-7b-like, transcript variant X4
ras-related protein Rab-7b-like, transcript variant X3
ras-related protein Rab-7b-like, transcript variant X5
ras-related protein Rab-7b-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor receptor substrate 2-like, transcript variant X1
fibroblast growth factor receptor substrate 2-like, transcript variant X4
fibroblast growth factor receptor substrate 2-like, transcript variant X2
fibroblast growth factor receptor substrate 2-like, transcript variant X3
fibroblast growth factor receptor substrate 2-like isoform X1
fibroblast growth factor receptor substrate 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
fibroblast growth factor receptor substrate 2-like isoform X2
prickle-like protein 1, transcript variant X3
prickle-like protein 1, transcript variant X2
prickle-like protein 1, transcript variant X1
daf-12-interacting protein 1-like, transcript variant X3
daf-12-interacting protein 1-like, transcript variant X2
daf-12-interacting protein 1-like, transcript variant X4
daf-12-interacting protein 1-like, transcript variant X1
daf-12-interacting protein 1-like isoform X2
uncharacterized protein LOC125462834 isoform X1
ubiquitin carboxyl-terminal hydrolase 49-like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 49-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 49-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 49-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 49-like isoform X2
ubiquitin carboxyl-terminal hydrolase 49-like isoform X1
mediator complex subunit 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mediator complex subunit 20, transcript variant X2
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X2
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X1
transcription initiation factor TFIID subunit 8
plasma membrane calcium-transporting ATPase 1-like, transcript variant X2
plasma membrane calcium-transporting ATPase 1-like, transcript variant X1
plasma membrane calcium-transporting ATPase 1-like, transcript variant X4
plasma membrane calcium-transporting ATPase 1-like, transcript variant X3
plasma membrane calcium-transporting ATPase 1-like isoform X4
plasma membrane calcium-transporting ATPase 2-like isoform X2
plasma membrane calcium-transporting ATPase 1-like isoform X3
plasma membrane calcium-transporting ATPase 1-like isoform X1
plasma membrane calcium-transporting ATPase 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 3-like isoform X6
plasma membrane calcium-transporting ATPase 3-like isoform X5
proline/arginine-rich end leucine-rich repeat protein, transcript variant X2
proline/arginine-rich end leucine-rich repeat protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: acidic mammalian chitinase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
acidic mammalian chitinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acidic mammalian chitinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acidic mammalian chitinase-like isoform X1
acidic mammalian chitinase-like isoform X2
cleavage and polyadenylation specificity factor subunit 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 6-like, transcript variant X3
cleavage and polyadenylation specificity factor subunit 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 6-like isoform X3
cleavage and polyadenylation specificity factor subunit 6-like isoform X2
cleavage and polyadenylation specificity factor subunit 6-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
protein pitchfork-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein pitchfork-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acidic mammalian chitinase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acidic mammalian chitinase-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Ras association domain family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras association domain-containing protein 5 isoform X1
Ras association domain family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras association domain-containing protein 5 isoform X2
TBC1 domain family member 30-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TBC1 domain family member 30-like, transcript variant X1
eukaryotic translation initiation factor 2D
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X4
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X2
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X3
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X4
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase peripheral stalk-membrane subunit b
ATP synthase F(0) complex subunit B1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transcription factor SFL2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transcription factor SFL2, transcript variant X2
uncharacterized protein PB18E9.04c isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
interferon regulatory factor 6, transcript variant X2
interferon regulatory factor 6, transcript variant X3
interferon regulatory factor 6, transcript variant X1
interferon regulatory factor 6, transcript variant X4
vitamin K-dependent protein Z-like, transcript variant X2
vitamin K-dependent protein Z-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
vitamin K-dependent protein Z-like isoform X1
vitamin K-dependent protein Z-like isoform X2
coagulation factor IX-like, transcript variant X2
coagulation factor IX-like, transcript variant X1
chromosome 22 C1orf74 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
chromosome 22 C1orf74 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TRAF3-interacting JNK-activating modulator, transcript variant X6
TRAF3-interacting JNK-activating modulator, transcript variant X5
TRAF3-interacting JNK-activating modulator, transcript variant X3
TRAF3-interacting JNK-activating modulator, transcript variant X1
TRAF3-interacting JNK-activating modulator, transcript variant X2
TRAF3-interacting JNK-activating modulator, transcript variant X4
TRAF3-interacting JNK-activating modulator isoform X6
TRAF3-interacting JNK-activating modulator isoform X5
TRAF3-interacting JNK-activating modulator isoform X3
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3-interacting JNK-activating modulator isoform X2
TRAF3-interacting JNK-activating modulator isoform X4
uncharacterized LOC125462911, transcript variant X1
uncharacterized LOC125462911, transcript variant X2
laminin subunit beta-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
laminin subunit beta-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
laminin subunit beta-3-like, transcript variant X3
calcium/calmodulin-dependent protein kinase type 1D-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1D-like, transcript variant X1
calcium/calmodulin-dependent protein kinase type 1D-like
specifically androgen-regulated gene protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
specifically androgen-regulated gene protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
specifically androgen-regulated gene protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
CUB and sushi domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like
C4b-binding protein-like, transcript variant X7
C4b-binding protein-like, transcript variant X1
C4b-binding protein-like, transcript variant X3
C4b-binding protein-like, transcript variant X2
C4b-binding protein-like, transcript variant X4
C4b-binding protein-like, transcript variant X5
C4b-binding protein alpha chain-like isoform X5
C4b-binding protein-like, transcript variant X6
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X4
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125463020, transcript variant X10
uncharacterized LOC125463020, transcript variant X5
uncharacterized LOC125463020, transcript variant X1
uncharacterized LOC125463020, transcript variant X2
uncharacterized LOC125463020, transcript variant X6
uncharacterized LOC125463020, transcript variant X7
uncharacterized LOC125463020, transcript variant X3
uncharacterized LOC125463020, transcript variant X8
uncharacterized LOC125463020, transcript variant X4
uncharacterized LOC125463020, transcript variant X9
uncharacterized protein LOC125463020 isoform X1
uncharacterized protein LOC125463020 isoform X2
uncharacterized protein LOC125463020 isoform X6
uncharacterized protein LOC125463020 isoform X7
uncharacterized protein LOC125463020 isoform X3
uncharacterized protein LOC125463020 isoform X8
uncharacterized protein LOC125463020 isoform X4
uncharacterized protein LOC125463020 isoform X9
uncharacterized protein LOC125463020 isoform X5
uncharacterized protein LOC125463020 isoform X10
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X6
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X5
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X6
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X5
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X3
uncharacterized LOC125462909, transcript variant X1
uncharacterized LOC125462909, transcript variant X2
uncharacterized LOC125462884, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC125462884, transcript variant X1
uncharacterized protein LOC125462884 isoform X1
uncharacterized protein LOC125462884 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
olfactory receptor class A-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LHFPL tetraspan subfamily member 5 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SRSF protein kinase 1-like, transcript variant X1
SRSF protein kinase 1-like, transcript variant X2
cilia and flagella associated protein 276
endosome-lysosome associated apoptosis and autophagy regulator 1, transcript variant X1
endosome/lysosome-associated apoptosis and autophagy regulator 1 isoform X1
endosome-lysosome associated apoptosis and autophagy regulator 1, transcript variant X2
endosome/lysosome-associated apoptosis and autophagy regulator 1 isoform X2
cadherin, EGF LAG seven-pass G-type receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cadherin, EGF LAG seven-pass G-type receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cadherin, EGF LAG seven-pass G-type receptor 2, transcript variant X2
cadherin, EGF LAG seven-pass G-type receptor 2, transcript variant X4
cadherin EGF LAG seven-pass G-type receptor 2 isoform X2
cadherin EGF LAG seven-pass G-type receptor 2 isoform X4
cadherin EGF LAG seven-pass G-type receptor 2 isoform X1
cadherin EGF LAG seven-pass G-type receptor 2 isoform X3
proline/serine-rich coiled-coil protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
proline/serine-rich coiled-coil protein 1-like, transcript variant X1
proline/serine-rich coiled-coil protein 1-like, transcript variant X5
proline/serine-rich coiled-coil protein 1-like, transcript variant X2
proline/serine-rich coiled-coil protein 1-like, transcript variant X3
proline/serine-rich coiled-coil protein 1-like isoform X2
proline/serine-rich coiled-coil protein 1-like isoform X1
proline/serine-rich coiled-coil protein 1-like isoform X3
peptidylprolyl isomerase (cyclophilin)-like 1, transcript variant X1
peptidyl-prolyl cis-trans isomerase-like 1 isoform X1
peptidylprolyl isomerase (cyclophilin)-like 1, transcript variant X2
peptidyl-prolyl cis-trans isomerase-like 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kinesin family member 21B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
kinesin family member 21B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 21B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
kinesin family member 21B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 21B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Pim-1 proto-oncogene, serine/threonine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
TBC1 domain family, member 22B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBC1 domain family, member 22B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TBC1 domain family member 22B isoform X1
TBC1 domain family member 22B isoform X2
chemokine-like protein TAFA-5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chemokine-like protein TAFA-5 isoform X2
chemokine-like protein TAFA-5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chemokine-like protein TAFA-5, transcript variant X4
chemokine-like protein TAFA-5, transcript variant X1
chemokine-like protein TAFA-5, transcript variant X3
chemokine-like protein TAFA-5 isoform X4
chemokine-like protein TAFA-5 isoform X3
chemokine-like protein TAFA-5 isoform X1
bromodomain and PHD finger-containing protein 3-like, transcript variant X1
bromodomain and PHD finger-containing protein 3-like, transcript variant X2
bromodomain and PHD finger-containing protein 3-like, transcript variant X3
bromodomain and PHD finger-containing protein 3-like
bromodomain and PHD finger-containing protein 3-like, transcript variant X4
mitogen-activated protein kinase 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitogen-activated protein kinase 14, transcript variant X2
mitogen-activated protein kinase 14, transcript variant X1
mitogen-activated protein kinase 14 isoform X2
mitogen-activated protein kinase 14 isoform X1
uncharacterized LOC125462915, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125462915, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
innate immunity activator protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
innate immunity activator protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
innate immunity activator protein-like, transcript variant X5
innate immunity activator protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
innate immunity activator protein-like, transcript variant X4
innate immunity activator protein-like isoform X1
innate immunity activator protein-like isoform X2
arginyl aminopeptidase (aminopeptidase B), transcript variant X1
arginyl aminopeptidase (aminopeptidase B), transcript variant X2
translocase of inner mitochondrial membrane 17 homolog A (yeast)
mitochondrial import inner membrane translocase subunit Tim17-A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
bombesin receptor-activated protein C6orf89 homolog
high mobility group AT-hook 1a, transcript variant X1
high mobility group AT-hook 1a, transcript variant X3
high mobility group AT-hook 1a isoform X1
high mobility group AT-hook 1a isoform X3
high mobility group AT-hook 1a, transcript variant X2
high mobility group AT-hook 1a isoform X2
high mobility group AT-hook 1a, transcript variant X4
high mobility group AT-hook 1a isoform X4
small integral membrane protein 29, transcript variant X2
small integral membrane protein 29, transcript variant X1
small integral membrane protein 29 isoform X2
small integral membrane protein 29 isoform X1
suppressor of cytokine signaling 2-like, transcript variant X1
suppressor of cytokine signaling 2-like, transcript variant X4
suppressor of cytokine signaling 2-like, transcript variant X3
suppressor of cytokine signaling 2-like, transcript variant X2
suppressor of cytokine signaling 2-like, transcript variant X5
diphosphoinositol polyphosphate phosphohydrolase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor, type 3
inositol 1,4,5-trisphosphate receptor type 3
ubiquinol-cytochrome-c reductase complex assembly factor 2
metabotropic glutamate receptor 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
metabotropic glutamate receptor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
metabotropic glutamate receptor 4-like, transcript variant X4
metabotropic glutamate receptor 4-like, transcript variant X6
metabotropic glutamate receptor 4-like, transcript variant X2
metabotropic glutamate receptor 4-like isoform X1
metabotropic glutamate receptor 4-like isoform X3
metabotropic glutamate receptor 4-like isoform X2
metabotropic glutamate receptor 4-like isoform X5
metabotropic glutamate receptor 4-like, transcript variant X5
metabotropic glutamate receptor 4-like isoform X4
ubiquitin-conjugating enzyme E2T (putative), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2T (putative), transcript variant X1
leucine-rich repeat-containing G-protein coupled receptor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase R-like, transcript variant X1
receptor-type tyrosine-protein phosphatase R-like, transcript variant X2
receptor-type tyrosine-protein phosphatase R-like
immunoglobulin-like and fibronectin type III domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
troponin T type 2a (cardiac), transcript variant X4
troponin T type 2a (cardiac), transcript variant X3
troponin T type 2a (cardiac), transcript variant X1
troponin T type 2a (cardiac), transcript variant X2
troponin T type 2a (cardiac), transcript variant X6
troponin T type 2a (cardiac), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64% coverage of the annotated genomic feature by RNAseq alignments
troponin I type 1b (skeletal, slow), transcript variant X1
troponin I type 1b (skeletal, slow), transcript variant X2
pleckstrin homology-like domain family A member 3
cysteine and glycine-rich protein 1-like
neuron navigator 1-like, transcript variant X1
neuron navigator 1-like, transcript variant X2
neuron navigator 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuron navigator 1-like, transcript variant X3
protein phosphatase 1 regulatory subunit 12B-like, transcript variant X5
protein phosphatase 1 regulatory subunit 12B-like, transcript variant X4
protein phosphatase 1 regulatory subunit 12B-like, transcript variant X2
protein phosphatase 1 regulatory subunit 12B-like, transcript variant X3
protein phosphatase 1 regulatory subunit 12B-like, transcript variant X1
protein phosphatase 1 regulatory subunit 12B-like, transcript variant X6
protein phosphatase 1 regulatory subunit 12B-like isoform X2
protein phosphatase 1 regulatory subunit 12B-like isoform X3
protein phosphatase 1 regulatory subunit 12B-like isoform X1
protein phosphatase 1 regulatory subunit 12B-like isoform X4
protein phosphatase 1 regulatory subunit 12B-like isoform X5
adenosine receptor A1-like, transcript variant X2
adenosine receptor A1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X1
PTPRF interacting protein alpha 4, transcript variant X2
PTPRF interacting protein alpha 4, transcript variant X3
transmembrane protein 183A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 183A, transcript variant X1
transmembrane protein 183A, transcript variant X4
transmembrane protein 183A, transcript variant X3
transmembrane protein 183A, transcript variant X5
complement C1q-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
complement C1q-like protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
complement C1q-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
complement C1q-like protein 3 isoform X1
complement C1q-like protein 3 isoform X3
complement C1q-like protein 3 isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like, transcript variant X4
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like isoform X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C-like isoform X1
tetraspanin-18-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tetraspanin-18-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X1
tetraspanin-18-like, transcript variant X16
tetraspanin-18-like, transcript variant X7
tetraspanin-18-like, transcript variant X8
tetraspanin-18-like, transcript variant X4
tetraspanin-18-like, transcript variant X15
tetraspanin-18-like, transcript variant X9
tetraspanin-18-like, transcript variant X14
tetraspanin-18-like, transcript variant X5
tetraspanin-18-like, transcript variant X2
tetraspanin-18-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tetraspanin-18-like, transcript variant X10
makorin, ring finger protein, 4, transcript variant X2
makorin, ring finger protein, 4, transcript variant X1
makorin, ring finger protein, 4 isoform X2
makorin, ring finger protein, 4 isoform X1
peroxisome proliferator-activated receptor delta b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 217 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
peroxisome proliferator-activated receptor delta b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 217 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peroxisome proliferator-activated receptor delta b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 217 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peroxisome proliferator-activated receptor delta b
differentially expressed in FDCP 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 76-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 76-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 76-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
signal peptide, CUB and EGF-like domain-containing protein 3
T-complex protein 11-like protein 1, transcript variant X3
T-complex protein 11-like protein 1, transcript variant X1
T-complex protein 11-like protein 1, transcript variant X2
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X7
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X3
ankyrin repeat and SAM domain-containing protein 1A-like isoform X7
ankyrin repeat and SAM domain-containing protein 1A-like isoform X3
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A-like isoform X11
ankyrin repeat and SAM domain-containing protein 1A-like isoform X10
ankyrin repeat and SAM domain-containing protein 1A-like isoform X5
ankyrin repeat and SAM domain-containing protein 1A-like isoform X9
ankyrin repeat and SAM domain-containing protein 1A-like isoform X4
ankyrin repeat and SAM domain-containing protein 1A-like isoform X2
ankyrin repeat and SAM domain-containing protein 1A-like isoform X6
ankyrin repeat and SAM domain-containing protein 1A-like isoform X1
ankyrin repeat and SAM domain-containing protein 1A-like isoform X8
TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transcription initiation factor TFIID subunit 11
UHRF1 binding protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UHRF1 binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UHRF1 binding protein 1, transcript variant X6
UHRF1 binding protein 1, transcript variant X4
UHRF1 binding protein 1, transcript variant X5
UHRF1 binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
UHRF1 binding protein 1, transcript variant X1
UHRF1 binding protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X1
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X2
SAM pointed domain-containing Ets transcription factor
protein kinase C and casein kinase substrate in neurons 1b
protein kinase C and casein kinase substrate in neurons protein 1
polyglutamylase complex subunit TTLL1-like, transcript variant X1
polyglutamylase complex subunit TTLL1-like isoform X1
polyglutamylase complex subunit TTLL1-like, transcript variant X2
polyglutamylase complex subunit TTLL1-like isoform X2
bcl-2 homologous antagonist/killer-like, transcript variant X8
bcl-2 homologous antagonist/killer-like, transcript variant X2
bcl-2 homologous antagonist/killer-like, transcript variant X11
bcl-2 homologous antagonist/killer-like, transcript variant X3
bcl-2 homologous antagonist/killer-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bcl-2 homologous antagonist/killer-like, transcript variant X4
bcl-2 homologous antagonist/killer-like, transcript variant X9
bcl-2 homologous antagonist/killer-like, transcript variant X7
bcl-2 homologous antagonist/killer-like, transcript variant X6
bcl-2 homologous antagonist/killer-like, transcript variant X1
bcl-2 homologous antagonist/killer-like, transcript variant X5
translocator protein-like, transcript variant X2
translocator protein-like, transcript variant X1
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a
ADP-ribose glycohydrolase OARD1-like, transcript variant X2
ADP-ribose glycohydrolase OARD1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ADP-ribose glycohydrolase OARD1-like isoform X1
ADP-ribose glycohydrolase OARD1-like isoform X2
ETS-related transcription factor Elf-3-like
adaptor related protein complex 4 subunit beta 1, transcript variant X1
adaptor related protein complex 4 subunit beta 1, transcript variant X2
adaptor related protein complex 4 subunit beta 1, transcript variant X4
adaptor related protein complex 4 subunit beta 1, transcript variant X5
adaptor related protein complex 4 subunit beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DNA cross-link repair 1B, transcript variant X4
DNA cross-link repair 1B, transcript variant X2
DNA cross-link repair 1B, transcript variant X1
DNA cross-link repair 1B, transcript variant X5
DNA cross-link repair 1B, transcript variant X6
DNA cross-link repair 1B, transcript variant X7
DNA cross-link repair 1B, transcript variant X3
DNA cross-link repair 1B, transcript variant X8
DELTA-thalatoxin-Avl1a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DELTA-thalatoxin-Avl1a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
homeodomain-interacting protein kinase 1-like, transcript variant X3
homeodomain-interacting protein kinase 1-like, transcript variant X1
homeodomain-interacting protein kinase 1-like, transcript variant X4
homeodomain-interacting protein kinase 1-like, transcript variant X5
homeodomain-interacting protein kinase 1-like, transcript variant X6
homeodomain-interacting protein kinase 1-like, transcript variant X2
homeodomain-interacting protein kinase 1-like isoform X1
homeodomain-interacting protein kinase 1-like isoform X2
homeodomain-interacting protein kinase 1-like isoform X3
homeodomain-interacting protein kinase 1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
methylmalonyl-CoA epimerase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
tripartite motif containing 33, transcript variant X1
tripartite motif containing 33, transcript variant X2
E3 ubiquitin-protein ligase TRIM33 isoform X2
E3 ubiquitin-protein ligase TRIM33 isoform X1
ras association domain-containing protein 8-like, transcript variant X1
ras association domain-containing protein 8-like isoform X1
ras association domain-containing protein 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras association domain-containing protein 8-like isoform X2
adenosine monophosphate deaminase 1 (isoform M), transcript variant X1
adenosine monophosphate deaminase 1 (isoform M), transcript variant X2
NRAS proto-oncogene, GTPase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 176 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
NRAS proto-oncogene, GTPase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 176 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
NRAS proto-oncogene, GTPase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 176 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NRAS proto-oncogene, GTPase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 176 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 1-like
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X4
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X5
sphingomyelin phosphodiesterase 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
sphingomyelin phosphodiesterase 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transcriptional enhancer factor TEF-5-like
uncharacterized LOC125462771, transcript variant X1
uncharacterized LOC125462771, transcript variant X2
tubby-related protein 3-like, transcript variant X4
tubby-related protein 3-like, transcript variant X3
tubby-related protein 3-like, transcript variant X12
tubby-related protein 3-like, transcript variant X2
tubby-related protein 3-like, transcript variant X10
tubby-related protein 3-like, transcript variant X1
tubby-related protein 3-like, transcript variant X6
tubby-related protein 3-like, transcript variant X11
tubby-related protein 3-like, transcript variant X9
tubby-related protein 3-like, transcript variant X8
tubby-related protein 3-like, transcript variant X5
tubby-related protein 3-like, transcript variant X7
peptidyl-prolyl cis-trans isomerase FKBP5-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase FKBP5-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP5-like isoform X1
peptidyl-prolyl cis-trans isomerase FKBP5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
DENN domain-containing protein 2C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DENN domain-containing protein 2C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DENN domain-containing protein 2C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DENN domain-containing protein 2C-like isoform X1
DENN domain-containing protein 2C-like isoform X2
AT-rich interactive domain-containing protein 2-like, transcript variant X1
AT-rich interactive domain-containing protein 2-like isoform X1
AT-rich interactive domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
AT-rich interactive domain-containing protein 2-like isoform X2
cold shock domain containing E1, RNA-binding, transcript variant X7
cold shock domain containing E1, RNA-binding, transcript variant X4
cold shock domain containing E1, RNA-binding, transcript variant X6
cold shock domain containing E1, RNA-binding, transcript variant X5
cold shock domain containing E1, RNA-binding, transcript variant X3
cold shock domain containing E1, RNA-binding, transcript variant X2
cold shock domain containing E1, RNA-binding, transcript variant X1
cold shock domain-containing protein E1 isoform X6
cold shock domain-containing protein E1 isoform X5
cold shock domain-containing protein E1 isoform X3
cold shock domain-containing protein E1 isoform X2
cold shock domain-containing protein E1 isoform X1
cold shock domain-containing protein E1 isoform X4
cold shock domain-containing protein E1 isoform X7
bile acid receptor-like, transcript variant X1
bile acid receptor-like, transcript variant X2
sodium-coupled monocarboxylate transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 5 member 8, like, transcript variant X2
solute carrier family 5 member 8, like, transcript variant X1
solute carrier family 5 member 8, like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium-coupled monocarboxylate transporter 1 isoform X2
sodium-coupled monocarboxylate transporter 1 isoform X1
sodium-coupled monocarboxylate transporter 1 isoform X4
solute carrier family 5 member 8, like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-coupled monocarboxylate transporter 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125462917, transcript variant X2
uncharacterized LOC125462917, transcript variant X1
uncharacterized protein LOC125462917 isoform X2
uncharacterized protein LOC125462917 isoform X1
BH3-interacting domain death agonist-like
kelch-like family member 12, transcript variant X3
kelch-like family member 12, transcript variant X1
kelch-like family member 12, transcript variant X2
adiponectin receptor protein 1-like, transcript variant X1
adiponectin receptor protein 1-like, transcript variant X2
adiponectin receptor protein 1-like isoform X1
adiponectin receptor protein 1-like isoform X2
mitochondrial ribosomal protein L16, transcript variant X2
mitochondrial ribosomal protein L16, transcript variant X1
39S ribosomal protein L16, mitochondrial isoform X2
39S ribosomal protein L16, mitochondrial isoform X1
uncharacterized protein LOC100005854 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC100005854 homolog, transcript variant X1
uncharacterized protein LOC100005854 homolog, transcript variant X3
ETS variant transcription factor 7, transcript variant X3
ETS variant transcription factor 7, transcript variant X6
ETS variant transcription factor 7, transcript variant X2
ETS variant transcription factor 7, transcript variant X1
ETS variant transcription factor 7, transcript variant X4
ETS variant transcription factor 7, transcript variant X5
omega-hydroxyceramide transacylase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
omega-hydroxyceramide transacylase-like isoform X2
omega-hydroxyceramide transacylase-like, transcript variant X3
omega-hydroxyceramide transacylase-like, transcript variant X1
omega-hydroxyceramide transacylase-like isoform X1
omega-hydroxyceramide transacylase-like isoform X3
mitochondrial glutamate carrier 1-like, transcript variant X2
mitochondrial glutamate carrier 1-like, transcript variant X1
mitochondrial glutamate carrier 1-like isoform X1
mitochondrial glutamate carrier 1-like isoform X2
serine/threonine-protein kinase 38, transcript variant X5
serine/threonine-protein kinase 38, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein kinase 38, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein kinase 38, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
serine/threonine-protein kinase 38, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
serine/threonine-protein kinase 38 isoform X2
serine/threonine-protein kinase 38 isoform X1
BTB/POZ domain-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
cyclin-dependent kinase inhibitor 1B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
uncharacterized LOC125462987, transcript variant X3
uncharacterized LOC125462987, transcript variant X5
uncharacterized LOC125462987, transcript variant X1
uncharacterized LOC125462987, transcript variant X2
uncharacterized LOC125462987, transcript variant X4
26S proteasome non-ATPase regulatory subunit 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transmembrane protein 263-like, transcript variant X3
transmembrane protein 263-like, transcript variant X2
transmembrane protein 263-like isoform X2
transmembrane protein 263-like, transcript variant X1
transmembrane protein 263-like isoform X1
transmembrane protein 263-like isoform X3
cryptochrome-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cryptochrome-1-like, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DNA damage-regulated autophagy modulator protein 2-like, transcript variant X1
DNA damage-regulated autophagy modulator protein 2-like, transcript variant X3
DNA damage-regulated autophagy modulator protein 2-like, transcript variant X2
DNA damage-regulated autophagy modulator protein 2-like
synaptonemal complex protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
synaptonemal complex protein 3 isoform X1
synaptonemal complex protein 3, transcript variant X2
synaptonemal complex protein 3 isoform X2
choline/ethanolaminephosphotransferase 1-like, transcript variant X1
choline/ethanolaminephosphotransferase 1-like, transcript variant X2
choline/ethanolaminephosphotransferase 1-like isoform X1
choline/ethanolaminephosphotransferase 1-like isoform X2
voltage-dependent L-type calcium channel subunit alpha-1S-like, transcript variant X2
voltage-dependent L-type calcium channel subunit alpha-1S-like, transcript variant X3
voltage-dependent L-type calcium channel subunit alpha-1S-like, transcript variant X1
voltage-dependent L-type calcium channel subunit alpha-1S-like isoform X2
voltage-dependent L-type calcium channel subunit alpha-1S-like isoform X3
voltage-dependent L-type calcium channel subunit alpha-1S-like isoform X1
voltage-dependent L-type calcium channel subunit alpha-1S-like, transcript variant X4
voltage-dependent L-type calcium channel subunit alpha-1S-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 268 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lysine-specific demethylase 5B-like, transcript variant X3
lysine-specific demethylase 5B-like, transcript variant X1
lysine-specific demethylase 5B-like, transcript variant X2
lysine-specific demethylase 5B-like isoform X1
lysine-specific demethylase 5B-like isoform X2
lysine-specific demethylase 5B-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily A member 10-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 161 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: potassium voltage-gated channel subfamily A member 10-like
potassium voltage-gated channel subfamily A member 2-like, transcript variant X2
potassium voltage-gated channel subfamily A member 2-like, transcript variant X1
potassium voltage-gated channel subfamily A member 2-like, transcript variant X3
potassium voltage-gated channel subfamily A member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
thyrotropin-releasing hormone receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
phospholipid phosphatase-related protein type 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phospholipid phosphatase-related protein type 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phospholipid phosphatase-related protein type 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
phospholipid phosphatase-related protein type 5-like isoform X3
phospholipid phosphatase-related protein type 5-like isoform X1
phospholipid phosphatase-related protein type 5-like isoform X2